Why Job Boards Trump Social Media  | View as HTML Post Jobs Search Resumes Email Preferences
BioSpaceLike Us on FacebookFollow us on TwitterLinkedInRSSSubscribe

Reach an extensive network of biotech and pharmaceutical professionals through the BioSpace Career Insider eNewsletter with a distribution to over 68,000 subscribers. Get $1,000 off the sponsorship price (regularly $2,495)! Hurry, though, offer ends March 25th by mentioning the promo code: CareerInsider1000 Contact your rep today!

Your Career

Why Job Boards Trump Social Media

News tickers, newspapers and news magazines seem to be full of headlines about the latest and greatest aspects of social media-particularly with the late 2012 launch of Facebook's Social Jobs Partnership. If you're a biopharma or life sciences employer or recruiter , you know it's all too easy to jump on the media bandwagon and ditch your old recruiting methods-like the job board. Read More.

Your Career

Walk Softly but Speak With Big Data

Let's be honest. Hiring managers are not our customers. At best, they are our allies, and at worst, they are our enemies. They hold the power to help or hinder our day-to-day work. But, our customers – the people who determine whether or not we're successful – are another group altogether. Read More.

We know your time is important, so let us help you save time recruiting through setting your jobs up for automatic posting. Ask us about this free service today! The best part is, we can even set this up for existing contracts, and it's completely maintenance free!

For more information about this productand other recruitment and advertising solutions, contact Biospace at (888) BIOSPACE or support@biospace.com today!
Astellas Pharma Inc. (YPH.BE) and Ambit Biosciences to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
Astellas Pharma Inc. (Astellas) (Tokyo: 4503) and Ambit Biosciences Corporation today announced the companies will end their collaboration for the joint development and commercialization of FMS-like tyrosine kinase-3 (FLT3) inhibitors, including quizartinib, effective September 3, 2013. Learn More »
Johnson & Johnson (JNJ) Cuts Executive Bonuses, Citing "Disappointments"
Johnson & Johnson's (JNJ) "mixed" performance in 2012 prompted its board to reduce the planned bonus for Chief Executive Alex Gorsky and other senior officers by 10%, the health-care giant disclosed Wednesday. Learn More »
Pfizer Inc. (PFE) Halts Development of Hepatitis C Drug
Pfizer Inc. (PFE) has stopped development of an experimental hepatitis C drug, bowing out of a hotly contested industry race to introduce the next generation of treatments for the infectious liver disease. Learn More »

Post Your:   News   |   Jobs   |   Company Profile   |   Event   |   Advertising/Sponsorship

This email was sent by BioSpace.com. Please distribute this e-cast freely. Subscribe to our newsletter. To unsubscribe or update your email preferences, click here. This request may take up to 10 business days to take effect.

BioSpace.com is an onTargetjobs, Inc. company and respects your time and privacy. BioSpace.com is not responsible for offers, products, services, or other information expressed or made available by third parties and provided by any off-site Internet page referenced through this email's hypertext. While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. To guarantee receipt of BioSpace.com emails, add newsletters@email.biospace.com to your address book.

Contact the News Team Email: news@biospace.com; Toll Free: (877) 277-7585; 6465 S. Greenwood Plaza Blvd., Ste. 400, Centennial, CO 80111
Send questions and comments to the BioSpace News Beat Team.
Editor & Publisher: Lana Ho
Editorial & Production Staff: Maysa Darwish, Tammy Liu

© 2012 onTargetjobs, Inc. All rights reserved. BioSpace.com is a registered trademark of onTargetjobs, Inc. All other trademarks and registered trademarks are the property of their respective owners.